CD34 and non-Hodgkin lymphoma: Specific cut-offs of mobilization capacity as manifested by peak blood CD34+ cell count as well as CD3+CD4+ T cells, CD3+CD8+ T cells, and NK cells in the infused graft seemed to predict early immune recovery, which is associated with a better outcome in NHL patients after transplantation.